Signal transduction during activation and inhibition of natural killer cells

Current Protocols in Immunology

Volumn , Issue SUPPL. 90, 2010, Pages

  Watzl, Carsten ^a   Long, Eric O ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

adhesion; cytotoxicity; natural killer cells; signal transduction

Indexed keywords

BETA1 INTEGRIN; BETA2 INTEGRIN; CD16 ANTIGEN; CD2 ANTIGEN; FC RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; LYMPHOCYTE MEMBRANE RECEPTOR; MEMBRANE PROTEIN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D; NECTIN 2; NKP80 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA1; PHOSPHOLIPASE C GAMMA2; PROTEIN 2B4; PROTEIN CRACC; PROTEIN KINASE D; PROTEIN KINASE D1; PROTEIN KINASE SYK; PROTEIN KINASE ZAP 70; PROTEIN NTB A; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VAV PROTEIN;

B LYMPHOCYTE; BINDING AFFINITY; CELL ACTIVITY; CELL ADHESION; CELL INTERACTION; DEGRANULATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; CELL COMMUNICATION; CYTOTOXICITY, IMMUNOLOGIC; FEEDBACK, PHYSIOLOGICAL; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; RECEPTOR CROSS-TALK; RECEPTORS, NATURAL KILLER CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 77956481004     PISSN: 19343671     EISSN: 1934368X     Source Type: Journal    
DOI: 10.1002/0471142735.im1109bs35     Document Type: Review

References (149)

1. Alon, R., and, Dustin, M.L., 2007. Force as a facilitator of integrin conformational changes during leukocyte arrest on blood vessels and antigen-presenting cells. Immunity 26: 17 - 27.
2. Andzelm, M.M., Chen, X., Krzewski, K., Orange, J.S., and, Strominger, J.L., 2007. Myosin IIA is required for cytolytic granule exocytosis in human NK cells. J. Exp. Med. 204: 2285 - 2291.
3. Anfossi, N., Andre, P., Guia, S., Falk, C.S., Roetynck, S., Stewart, C.A., Breso, V., Frassati, C., Reviron, D., Middleton, D., Romagne, F., Ugolini, S., and, Vivier, E., 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331 - 342.
4. Anikeeva, N., Somersalo, K., Sims, T.N., Thomas, V.K., Dustin, M.L., and, Sykulev, Y., 2005. Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 102: 6437 - 6442.
5. Arase, H., Mocarski, E.S., Campbell, A.E., Hill, A.B., and, Lanier, L.L., 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323 - 1326.
6. Arneson, L.N., Brickshawana, A., Segovis, C.M., Schoon, R.A., Dick, C.J., and, Leibson, P.J., 2007. Cutting edge: Syntaxin 11 regulates lymphocyte-mediated secretion and cytotoxicity. J. Immunol. 179: 3397 - 3401.
7. Arnon, T.I., Markel, G., and, Mandelboim, O., 2006. Tumor and viral recognition by natural killer cells receptors. Semin. Cancer Biol. 16: 348 - 358.
8. Ashkar, A.A., Di Santo, J.P., and, Croy, B.A., 2000. Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J. Exp. Med. 192: 259 - 269.
9. Banerjee, P.P., Pandey, R., Zheng, R., Suhoski, M.M., Monaco-Shawver, L., and, Orange, J.S., 2007. Cdc42-interacting protein-4 functionally links actin and microtubule networks at the cytolytic NK cell immunological synapse. J. Exp. Med. 204: 2305 - 2320.
10. Barber, D.F., and, Long, E.O., 2003. Coexpression of CD58 or CD48 with intercellular adhesion molecule 1 on target cells enhances adhesion of resting NK cells. J. Immunol. 170: 294 - 299.
11. Barber, D.F., Faure, M., and, Long, E.O., 2004. LFA-1 contributes an early signal for NK cell cytotoxicity. J. Immunol. 173: 3653 - 3659.
12. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J.H., Lanier, L.L., and, Spies, T., 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727 - 729.
13. Bell, G. M., Fargnoli, J., Bolen, J.B., Kish, L., and, Imboden, J.B., 1996. The SH3 domain of p56lck binds to proline-rich sequences in the cytoplasmic domain of CD2. J. Exp. Med. 183: 169 - 178.
14. Benoit, L., Wang, X., Pabst, H.F., Dutz, J., and, Tan, R., 2000. Defective NK cell activation in X-linked lymphoproliferative disease. J. Immunol. 165: 3549 - 3553.
15. Berditchevski, F., 2001. Complexes of tetraspanins with integrins: More than meets the eye. J. Cell Sci. 114: 4143 - 4151.
16. Billadeau, D.D., Brumbaugh, K.M., Dick, C.J., Schoon, R.A., Bustelo, X.R., and, Leibson, P.J., 1998. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing. J. Exp. Med. 188: 549 - 559.
17. Billadeau, D.D., Upshaw, J.L., Schoon, R.A., Dick, C.J., and, Leibson, P.J., 2003. NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nat. Immunol. 4: 557 - 564.
18. Bloch-Queyrat, C., Fondaneche, M.C., Chen, R., Yin, L., Relouzat, F., Veillette, A., Fischer, A., and, Latour, S., 2005. Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn. J. Exp. Med. 202: 181 - 192.
19. Bottino, C., Augugliaro, R., Castriconi, R., Nanni, M., Biassoni, R., Moretta, L., and, Moretta, A., 2000. Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: Evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells. Eur. J. Immunol. 30: 3718 - 3722.
20. Bottino, C., Falco, M., Parolini, S., Marcenaro, E., Augugliaro, R., Sivori, S., Landi, E., Biassoni, R., Notarangelo, L.D., Moretta, L., and, Moretta, A., 2001. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 194: 235 - 246.
21. Bottino, C., Castriconi, R., Pende, D., Rivera, P., Nanni, M., Carnemolla, B., Cantoni, C., Grassi, J., Marcenaro, S., Reymond, N., Vitale, M., Moretta, L., Lopez, M., and, Moretta, A., 2003. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J. Exp. M E d. 198: 557 - 567.
22. Bottino, C., Castriconi, R., Moretta, L., and, Moretta, A., 2005. Cellular ligands of activating NK receptors. Trends Immunol. 26: 221 - 226.
23. Bouchon, A., Cella, M., Grierson, H. L., Cohen, J.I., and, Colonna, M., 2001. Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J. Immunol. 167: 5517 - 5521.
24. Brandt, C.S., Baratin, M., Yi, E.C., Kennedy, J., Gao, Z., Fox, B., Haldeman, B., Ostrander, C.D., Kaifu, T., Chabannon, C., Moretta, A., West, R., Xu, W., Vivier, E., and, Levin, S.D., 2009. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J. Exp. Med. 206: 1495 - 1503.
25. Bryceson, Y.T., March, M.E., Barber, D.F., Ljunggren, H.G., and, Long, E.O., 2005. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J. Exp. Med. 202: 1001 - 1012.
26. Bryceson, Y.T., March, M.E., Ljunggren, H.G., and, Long, E.O., 2006a. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 214: 73 - 91.
27. Bryceson, Y.T., March, M.E., Ljunggren, H.G., and, Long, E.O., 2006b. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107: 159 - 166.
28. Bryceson, Y.T., Rudd, E., Zheng, C., Edner, J., Ma, D., Wood, S.M., Bechensteen, A.G., Boelens, J.J., Celkan, T., Farah, R.A., Hultenby, K., Winiarski, J., Roche, P.A., Nordenskjold, M., Henter, J.I., Long, E.O., and, Ljunggren, H.G., 2007. Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood 110: 1906 - 1915.
29. Burbach, B.J., Medeiros, R.B., Mueller, K.L., and, Shimizu, Y., 2007. T-cell receptor signaling to integrins. Immunol. Rev. 218: 65 - 81.
30. Burshtyn, D.N., Scharenberg, A.M., Wagtmann, N., Rajagopalan, S., Berrada, K., Yi, T., Kinet, J.P., and, Long, E.O., 1996. Recruitment of tyrosine phosphatase HCP (SHP-1) by the killer cell inhibitor receptor. Immunity 4: 77 - 85.
31. Byrd, A., Hoffmann, S.C., Jarahian, M., Momburg, F., and, Watzl, C., 2007. Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44. PLoS ONE 2: e1339.
32. Cantoni, C., Bottino, C., Vitale, M., Pessino, A., Augugliaro, R., Malaspina, A., Parolini, S., Moretta, L., Moretta, A., and, Biassoni, R., 1999. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J. Exp. Med. 189: 787 - 796.
33. Cantor, J.M., Ginsberg, M.H., and, Rose, D.M., 2008. Integrin-associated proteins as potential therapeutic targets. Immunol. Rev. 223: 236 - 251.
34. Caraux, A., Kim, N., Bell, S.E., Zompi, S., Ranson, T., Lesjean-Pottier, S., Garcia-Ojeda, M.E., Turner, M., and, Colucci, F., 2006. Phospholipase C-gamma2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells. Blood 107: 994 - 1002.
35. Cella, M., Fujikawa, K., Tassi, I., Kim, S., Latinis, K., Nishi, S., Yokoyama, W., Colonna, M., and, Swat, W., 2004. Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J. Exp. Med. 200: 817 - 823.
36. Chan, B., Lanyi, A., Song, H.K., Griesbach, J., Simarro-Grande, M., Poy, F., Howie, D., Sumegi, J., Terhorst, C., and, Eck, M.J., 2003. SAP couples Fyn to SLAM immune receptors. Nat. Cell. Biol. 5: 155 - 160.
37. Chan, G., Hanke, T., and, Fischer, K.D., 2001. Vav-1 regulates NK T cell development and NK cell cytotoxicity. Eur. J. Immunol. 31: 2403 - 2410.
38. Chen, R., Relouzat, F., Roncagalli, R., Aoukaty, A., Tan, R., Latour, S., and, Veillette, A., 2004. Molecular dissection of 2B4 signaling: Implications for signal transduction by SLAM-related receptors. Mol. Cell. Biol. 24: 5144 - 5156.
39. Cherukuri, A., Dykstra, M., and, Pierce, S.K., 2001. Floating the raft hypothesis: Lipid rafts play a role in immune cell activation. Immunity 14: 657 - 660.
40. Chiesa, S., Mingueneau, M., Fuseri, N., Malissen, B., Raulet, D.H., Malissen, M., Vivier, E., and, Tomasello, E., 2006. Multiplicity and plasticity of natural killer cell signaling pathways. Blood 107: 2364 - 2372.
41. Chlewicki, L.K., Velikovsky, C.A., Balakrishnan, V., Mariuzza, R.A., and, Kumar, V., 2008. Molecular basis of the dual functions of 2B4 (CD244). J. Immunol. 180: 8159 - 8167.
42. Ciccone, E., Pende, D., Viale, O., Than, A., Di Donato, C., Orengo, A.M., Biassoni, R., Verdiani, S., Amoroso, A., Moretta, A., and, Moretta, L., 1992. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J. Exp. Med. 176: 963 - 971.
43. Claus, M., Meinke, S., Bhat, R., and, Watzl, C., 2008. Regulation of NK cell activity by 2B4, NTB-A and CRACC. Front Biosci. 13: 956 - 965.
44. Colucci, F., Rosmaraki, E., Bregenholt, S., Samson, S.I., Di Bartolo, V., Turner, M., Vanes, L., Tybulewicz, V., and, Di Santo, J.P., 2001. Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms. J. Exp. Med. 193: 1413 - 1424.
45. Colucci, F., Schweighoffer, E., Tomasello, E., Turner, M., Ortaldo, J.R., Vivier, E., Tybulewicz, V.L., and, Di Santo, J.P., 2002. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat. Immunol. 3: 288 - 294.
46. Combs, J., Kim, S.J., Tan, S., Ligon, L.A., Holzbaur, E.L., Kuhn, J., and, Poenie, M., 2006. Recruitment of dynein to the Jurkat immunological synapse. Proc. Natl. Acad. Sci. U.S.A. 103: 14883 - 14888.
47. Cooper, M.A., Fehniger, T.A., Turner, S.C., Chen, K.S., Ghaheri, B.A., Ghayur, T., Carson, W.E., and, Caligiuri, M.A., 2001. Human natural killer cells: A unique innate immunoregulatory role for the CD56 bright subset. Blood 97: 3146 - 3151.
48. Cruz-Munoz, M.E., Dong, Z., Shi, X., Zhang, S., and, Veillette, A., 2009. Influence of CRACC, a SLAM family receptor coupled to the adaptor EAT-2, on natural killer cell function. Nat. Immunol. 10: 297 - 305.
49. Davis, S.J., Ikemizu, S., Wild, M.K., and, van der Merwe, P.A., 1998. CD2 and the nature of protein interactions mediating cell-cell recognition. Immunol. Rev. 163: 217 - 236.
50. Diefenbach, A., Tomasello, E., Lucas, M., Jamieson, A.M., Hsia, J.K., Vivier, E., and, Raulet, D.H., 2002. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 3: 1142 - 1149.
51. Eissmann, P., and, Watzl, C., 2006. Molecular analysis of NTB-A signaling: A role for EAT-2 in NTB-A-mediated activation of human NK cells. J. Immunol. 177: 3170 - 3177.
52. Eissmann, P., Beauchamp, L., Wooters, J., Tilton, J.C., Long, E.O., and, Watzl, C., 2005. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 105: 4722 - 4729.
53. Eleme, K., Taner, S.B., Onfelt, B., Collinson, L.M., McCann, F.E., Chalupny, N.J., Cosman, D., Hopkins, C., Magee, A.I., and, Davis, D.M., 2004. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D. J. Exp. Med. 199: 1005 - 1010.
54. Endt, J., McCann, F.E., Almeida, C.R., Urlaub, D., Leung, R., Pende, D., Davis, D.M., and, Watzl, C., 2007. Inhibitory receptor signals suppress ligation-induced recruitment of NKG2D to GM1-rich membrane domains at the human NK cell immune synapse. J. Immunol. 178: 5606 - 5611.
55. Fischer, A., Latour, S., and, de Saint Basile, G., 2007. Genetic defects affecting lymphocyte cytotoxicity. Curr. Opin. Immunol. 19: 348 - 353.
56. Fostel, L.V., Dluzniewska, J., Shimizu, Y., Burbach, B.J., and, Peterson, E.J., 2006. ADAP is dispensable for NK cell development and function. Int. Immunol. 18: 1305 - 1314.
57. Galandrini, R., Micucci, F., Tassi, I., Cifone, M.G., Cinque, B., Piccoli, M., Frati, L., and, Santoni, A., 2005. Arf6: A new player in FcgammaRIIIA lymphocyte-mediated cytotoxicity. Blood 106: 577 - 583.
58. Garrity, D., Call, M.E., Feng, J., and, Wucherpfennig, K.W., 2005. The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure. Proc. Natl. Acad. Sci. U.S.A. 102: 7641 - 7646.
59. Gasser, S., and, Raulet, D.H., 2006. Activation and self-tolerance of natural killer cells. Immunol. Rev. 214: 130 - 142.
60. Gasser, S., Orsulic, S., Brown, E.J., and, Raulet, D.H., 2005. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436: 1186 - 1190.
61. Geiger, C., Nagel, W., Boehm, T., van Kooyk, Y., Figdor, C.G., Kremmer, E., Hogg, N., Zeitlmann, L., Dierks, H., Weber, K.S., and, Kolanus, W., 2000. Cytohesin-1 regulates beta-2 integrin-mediated adhesion through both ARF-GEF function and interaction with LFA-1. EMBO J. 19: 2525 - 2536.
62. Gilfillan, S., Chan, C.J., Cella, M., Haynes, N.M., Rapaport, A.S., Boles, K.S., Andrews, D.M., Smyths, M.J., and, Colonna, M., 2008. DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors. J. Exp. Med. 205: 2965 - 2973.
63. Gismondi, A., Bisogno, L., Mainiero, F., Palmieri, G., Piccoli, M., Frati, L., and, Santoni, A., 1997. Proline-rich tyrosine kinase-2 activation by b 1 integrin fibronectin receptor cross-linking and association with paxillin in human natural killer cells. J. Immunol. 159: 4729 - 4736.
64. Gismondi, A., Jacobelli, J., Strippoli, R., Mainiero, F., Soriani, A., Cifaldi, L., Piccoli, M., Frati, L., and, Santoni, A., 2003. Proline-rich tyrosine kinase 2 and Rac activation by chemokine and integrin receptors controls NK cell transendothelial migration. J. Immunol. 170: 3065 - 3073.
65. Gismondi, A., Cifaldi, L., Mazza, C., Giliani, S., Parolini, S., Morrone, S., Jacobelli, J., Bandiera, E., Notarangelo, L., and, Santoni, A., 2004. Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: Ability of IL-2 to correct NK cell functional defect. Blood 104: 436 - 443.
66. Graham, D.B., Cella, M., Giurisato, E., Fujikawa, K., Miletic, A.V., Kloeppel, T., Brim, K., Takai, T., Shaw, A.S., Colonna, M., and, Swat, W., 2006. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics. J. Immunol. 177: 2349 - 2355.
67. Guerra, N., Tan, Y.X., Joncker, N.T., Choy, A., Gallardo, F., Xiong, N., Knoblaugh, S., Cado, D., Greenberg, N.M., and, Raulet, D.H., 2008. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 28: 571 - 580.
68. Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T.I., Manaster, I., Gazit, R., Yutkin, V., Benharroch, D., Porgador, A., Keshet, E., Yagel, S., and, Mandelboim, O., 2006. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 12: 1065 - 1074.
69. Hidalgo, A., and, Frenette, P.S., 2009. When integrins fail to integrate. Nat. Med. 15: 249 - 250.
70. Iguchi-Manaka, A., Kai, H., Yamashita, Y., Shibata, K., Tahara-Hanaoka, S., Honda, S., Yasui, T., Kikutani, H., Shibuya, K., and, Shibuya, A., 2008. Accelerated tumor growth in mice deficient in DNAM-1 receptor. J. Exp. Med. 205: 2959 - 2964.
71. Jakus, Z., Fodor, S., Abram, C.L., Lowell, C.A., and, Mocsai, A., 2007. Immunoreceptor-like signaling by beta 2 and beta 3 integrins. Trends Cell Biol. 17: 493 - 501.
72. Jiang, K., Zhong, B., Gilvary, D.L., Corliss, B.C., Hong-Geller, E., Wei, S., and, Djeu, J.Y., 2000. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat. Immunol. 1: 419 - 425.
73. Joncker, N.T., and, Raulet, D.H., 2008. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol. Rev. 224: 85 - 97.
74. Karlhofer, F.M., Ribaudo, R.K., and, Yokoyama, W.M., 1992. MHC class I alloantigen specificity of Ly-49 IL-2-activated natural killer cells. Nature 358: 66 - 70.
75. Kielczewska, A., Pyzik, M., Sun, T., Krmpotic, A., Lodoen, M.B., Munks, M.W., Babic, M., Hill, A.B., Koszinowski, U.H., Jonjic, S., Lanier, L.L., and, Vidal, S.M., 2009. Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J. Exp. Med. 206: 515 - 523.
76. Krzewski, K., Chen, X., and, Strominger, J.L., 2008. WIP is essential for lytic granule polarization and NK cell cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 105: 2568 - 2573.
77. Kuttruff, S., Koch, S., Kelp, A., Pawelec, G., Rammensee, H.G., and, Steinle, A., 2009. NKp80 defines and stimulates a reactive subset of CD8 T cells. Blood 113: 358 - 369.
78. Lanier, L.L., 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225 - 274.
79. Lanier, L.L., Yu, G., and, Phillips, J.H., 1991. Analysis of Fc gamma RIII (CD16) membrane expression and association with CD3 zeta and Fc epsilon RI-gamma by site-directed mutation. J. Immunol. 146: 1571 - 1576.
80. Lanier, L.L., Corliss, B.C., Wu, J., Leong, C., and, Phillips, J.H., 1998a. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391: 703 - 707.
81. Lanier, L.L., Corliss, B., Wu, J., and, Phillips, J.H., 1998b. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 8: 693 - 701.
82. Latour, S., Roncagalli, R., Chen, R., Bakinowski, M., Shi, X., Schwartzberg, P.L., Davidson, D., and, Veillette, A., 2003. Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation. Nat. Cell. Biol. 5: 149 - 154.
83. Lee, S.H., Miyagi, T., and, Biron, C.A., 2007. Keeping NK cells in highly regulated antiviral warfare. Trends Immunol. 28: 252 - 259.
84. Li, J., Nishizawa, K., An, W., Hussey, R.E., Lialios, F.E., Salgia, R., Sunder-Plassmann, R., and, Reinherz, E.L., 1998. A cdc15-like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2-triggered adhesion. EMBO J. 17: 7320 - 7336.
85. Li, C., Ge, B., Nicotra, M., Stern, J.N., Kopcow, H.D., Chen, X., and, Strominger, J.L., 2008. JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 105: 3017 - 3022.
86. Ljunggren, H.G., and, Krre, K., 1985. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 162: 1745 - 1759.
87. Long, E.O., 2008. Negative signaling by inhibitory receptors: The NK cell paradigm. Immunol. Rev. 224: 70 - 84.
88. Mace, E.M., Monkley, S.J., Critchley, D.R., and, Takei, F., 2009. A dual role for talin in NK cell cytotoxicity: Activation of LFA-1-mediated cell adhesion and polarization of NK cells. J. Immunol. 182: 948 - 956.
89. Mainiero, F., Gismondi, A., Soriani, A., Cippitelli, M., Palmieri, G., Jacobelli, J., Piccoli, M., Frati, L., and, Santoni, A., 1998. Integrin-mediated Ras-extracellular regulated kinase (ERK) signaling regulates interferon gamma production in human natural killer cells. J. Exp. Med. 188: 1267 - 1275.
90. Mainiero, F., Soriani, A., Strippoli, R., Jacobelli, J., Gismondi, A., Piccoli, M., Frati, L., and, Santoni, A., 2000. RAC1/P38 MAPK signaling pathway controls β1 integrin-induced interleukin-8 production in human natural killer cells. Immunity 12: 7 - 16.
91. Marcenaro, S., Gallo, F., Martini, S., Santoro, A., Griffiths, G.M., Arico, M., Moretta, L., and, Pende, D., 2006. Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): Defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood 108: 2316 - 2323.
92. Mason, L.H., Willette-Brown, J., Taylor, L.S., and, McVicar, D.W., 2006. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45. J. Immunol. 176: 6615 - 6623.
93. Menasche, G., Kliche, S., Chen, E.J., Stradal, T.E., Schraven, B., and, Koretzky, G., 2007. RIAM links the ADAP/SKAP-55 signaling module to Rap1, facilitating T-cell-receptor-mediated integrin activation. Mol. Cell Biol. 27: 4070 - 4081.
94. Micucci, F., Capuano, C., Marchetti, E., Piccoli, M., Frati, L., Santoni, A., and, Galandrini, R., 2008. PI5KI-dependent signals are critical regulators of the cytolytic secretory pathway. Blood 111: 4165 - 4172.
95. Miranti, C.K., Leng, L., Maschberger, P., Brugge, J.S., and, Shattil, S.J., 1998. Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1. Curr. Biol. 8: 1289 - 1299.
96. Mor, A., Dustin, M.L., and, Philips, M.R., 2007. Small GTPases and LFA-1 reciprocally modulate adhesion and signaling. Immunol. Rev. 218: 114 - 125.
97. Moretta, A., Marcenaro, E., Parolini, S., Ferlazzo, G., and, Moretta, L., 2008. NK cells at the interface between innate and adaptive immunity. Cell Death Differ. 15: 226 - 233.
98. Nakajima, H., Cella, M., Bouchon, A., Grierson, H.L., Lewis, J., Duckett, C.S., Cohen, J.I., and, Colonna, M., 2000. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur. J. Immunol. 30: 3309 - 3318.
99. Nguyen, K.B., Watford, W.T., Salomon, R., Hofmann, S.R., Pien, G.C., Morinobu, A., Gadina, M., OShea, J.J., and, Biron, C.A., 2002. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science 297: 2063 - 2066.
100. Nichols, K.E., Ma, C.S., Cannons, J.L., Schwartzberg, P.L., and, Tangye, S.G., 2005. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol. Rev. 203: 180 - 199.
101. Nolz, J.C., Medeiros, R.B., Mitchell, J.S., Zhu, P., Freedman, B.D., Shimizu, Y., and, Billadeau, D.D., 2007. WAVE2 regulates high-affinity integrin binding by recruiting vinculin and talin to the immunological synapse. Mol. Cell. Biol. 27: 5986 - 6000.
102. Nolz, J.C., Nacusi, L.P., Segovis, C.M., Medeiros, R.B., Mitchell, J.S., Shimizu, Y., and, Billadeau, D.D., 2008. The WAVE2 complex regulates T cell receptor signaling to integrins via Abl- and CrkL-C3G-mediated activation of Rap1. J. Cell Biol. 182: 1231 - 1244.
103. Orange, J.S., Ramesh, N., Remold-ODonnell, E., Sasahara, Y., Koopman, L., Byrne, M., Bonilla, F.A., Rosen, F.S., Geha, R.S., and, Strominger, J.L., 2002a. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc. Natl. Acad. Sci. U.S.A. 99: 11351 - 11356.
104. Orange, J.S., Brodeur, S.R., Jain, A., Bonilla, F.A., Schneider, L.C., Kretschmer, R., Nurko, S., Rasmussen, W.L., Khler, J.R., Gellis, S.E., Ferguson, B.M., Strominger, J.L., Zonana, J., Ramesh, N., Ballas, Z.K., and, Geha, R.S., 2002b. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J. Clin. Invest. 109: 1501 - 1509.
105. Orange, J.S., 2008. Formation and function of the lytic NK-cell immunological synapse. Nat. Rev. Immunol. 8: 713 - 725.
106. Parolini, S., Bottino, C., Falco, M., Augugliaro, R., Giliani, S., Franceschini, R., Ochs, H.D., Wolf, H., Bonnefoy, J.Y., Biassoni, R., Moretta, L., Notarangelo, L.D., and, Moretta, A., 2000. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 192: 337 - 346.
107. Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., Bottino, C., Moretta, L., and, Moretta, A., 1999. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 190: 1505 - 1516.
108. Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R., and, Moretta, A., 1998. Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med. 188: 953 - 960.
109. Peterson, M.E., and, Long, E.O., 2008. Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity 29: 578 - 588.
110. Porter, J.C., Bracke, M., Smith, A., Davies, D., and, Hogg, N., 2002. Signaling through integrin LFA-1 leads to filamentous actin polymerization and remodeling, resulting in enhanced T cell adhesion. J. Immunol. 168: 6330 - 6335.
111. Rajagopalan, S., Bryceson, Y.T., Kuppusamy, S.P., Geraghty, D.E., van der Meer, A., Joosten, I., and, Long, E.O., 2006. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol. 4: e9.
112. Ralston, K.J., Hird, S.L., Zhang, X., Scott, J.L., Jin, B., Thorne, R.F., Berndt, M.C., Boyd, A.W., and, Burns, G.F., 2004. The LFA-1-associated molecule PTA-1 (CD226) on T cells forms a dynamic molecular complex with protein 4.1G and human discs large. J. Biol. Chem. 279: 33816 - 33828.
113. Regunathan, J., Chen, Y., Kutlesa, S., Dai, X., Bai, L., Wen, R., Wang, D., and, Malarkannan, S., 2006. Differential and nonredundant roles of phospholipase Cgamma2 and phospholipase Cgamma1 in the terminal maturation of NK cells. J. Immunol. 177: 5365 - 5376.
114. Riteau, B., Barber, D.F., and, Long, E.O., 2003. Vav1 phosphorylation is induced by beta2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization. J. Exp. Med. 198: 469 - 474.
115. Roncagalli, R., Taylor, J.E., Zhang, S., Shi, X., Chen, R., Cruz-Munoz, M.E., Yin, L., Latour, S., and, Veillette, A., 2005. Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor. Nat. Immunol. 6: 1002 - 1010.
116. Saborit-Villarroya, I., Del Valle, J.M., Romero, X., Esplugues, E., Lauzurica, P., Engel, P., and, Martin, M., 2005. The adaptor protein 3BP2 binds human CD244 and links this receptor to Vav signaling, ERK activation, and NK cell killing. J. Immunol. 175: 4226 - 4235.
117. Sancho, D., Nieto, M., Llano, M., Rodrguez-Fernndez, J.L., Tejedor, R., Avraham, S., Cabaas, C., Lpez-Botet, M., and, Snchez-Madrid, F., 2000. The tyrosine kinase PYK-2/RAFTK regulates natural killer (NK) cell cytotoxic response, and is translocated and activated upon specific target cell recognition and killing. J. Cell Biol. 149: 1249 - 1261.
118. Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M.G., Oettgen, H., De Vries, J.E., Aversa, G., and, Terhorst, C., 1998. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395: 462 - 469.
119. Shibuya, A., Campbell, D., Hannum, C., Yssel, H., Franz-Bacon, K., McClanahan, T., Kitamura, T., Nicholl, J., Sutherland, G.R., Lanier, L.L., and, Phillips, J.H., 1996. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 4: 573 - 581.
120. Shibuya, K., Shirakawa, J., Kameyama, T., Honda, S., Tahara-Hanaoka, S., Miyamoto, A., Onodera, M., Sumida, T., Nakauchi, H., Miyoshi, H., and, Shibuya, A., 2003. CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J. Exp. Med. 198: 1829 - 1839.
121. Sirim, P., Zeitlmann, L., Kellersch, B., Falk, C.S., Schendel, D.J., and, Kolanus, W., 2001. Calcium signaling through the beta2-cytoplasmic domain of LFA-1 requires intracellular elements of the T cell receptor complex. J. Biol. Chem. 276: 42945 - 42956.
122. Sivori, S., Falco, M., Marcenaro, E., Parolini, S., Biassoni, R., Bottino, C., Moretta, L., and, Moretta, A., 2002. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc. Natl. Acad. Sci. U.S.A. 99: 4526 - 4531.
123. Smith, H.R.C., Heusel, J.W., Mehta, I.K., Kim, S., Dorner, B.G., Naidenko, O.V., Iizuka, K., Furukawa, H., Beckman, D.L., Pingel, J.T., Scalzo, A.A., Fremont, D.H., and, Yokoyama, W.M., 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. U.S.A. 99: 8826 - 8831.
124. Smith, K.M., Wu, J., Bakker, A.B., Phillips, J.H., and, Lanier, L.L., 1998. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J. Immunol. 161: 7 - 10.
125. Smyth, M.J., Hayakawa, Y., Takeda, K., and, Yagita, H., 2002. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat. Rev. Cancer 2: 850 - 861.
126. Stinchcombe, J.C., and, Griffiths, G.M., 2007. Secretory mechanisms in cell-mediated cytotoxicity. Annu. Rev. Cell Dev. Biol. 23: 495 - 517.
127. Strowig, T., Brilot, F., and, Munz, C., 2008. Noncytotoxic functions of NK cells: Direct pathogen restriction and assistance to adaptive immunity. J. Immunol. 180: 7785 - 7791.
128. Tahara-Hanaoka, S., Shibuya, K., Onoda, Y., Zhang, H., Yamazaki, S., Miyamoto, A., Honda, S., Lanier, L.L., and, Shibuya, A., 2004. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Int. Immunol. 16: 533 - 538.
129. Tangye, S.G., Phillips, J.H., Lanier, L.L., and, Nichols, K.E., 2000. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J. Immunol. 165: 2932 - 2936.
130. Tassi, I., Klesney-Tait, J., and, Colonna, M., 2006. Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse. Immunol. Rev. 214: 92 - 105.
131. Tassi, I., Presti, R., Kim, S., Yokoyama, W.M., Gilfillan, S., and, Colonna, M., 2005. Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors. J. Immunol. 175: 749 - 754.
132. Ting, A.T., Karnitz, L.M., Schoon, R.A., Abraham, R.T., and, Leibson, P.J., 1992. Fcγ receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-γ1 and PLC-γ2 in natural killer cells. J. Exp. Med. 176: 1751 - 1755.
133. Upshaw, J.L., Schoon, R.A., Dick, C.J., Billadeau, D.D., and, Leibson, P.J., 2005. The isoforms of phospholipase C-gamma are differentially used by distinct human NK activating receptors. J. Immunol. 175: 213 - 218.
134. Upshaw, J.L., Arneson, L.N., Schoon, R.A., Dick, C.J., Billadeau, D.D., and, Leibson, P.J., 2006. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells. Nat. Immunol. 7: 524 - 532.
135. van Oers, N.S., Lowin-Kropf, B., Finlay, D., Connolly, K., and, Weiss, A., 1996. Alpha beta T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases. Immunity 5: 429 - 436.
136. Veillette, A., 2006. NK cell regulation by SLAM family receptors and SAP-related adapters. Immunol. Rev. 214: 22 - 34. (Pubitemid 44707899)
137. Vitale, M., Falco, M., Castriconi, R., Parolini, S., Zambello, R., Semenzato, G., Biassoni, R., Bottino, C., Moretta, L., and, Moretta, A., 2001. Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur. J. Immunol. 31: 233 - 242.
138. Vivier, E., Spits, H., and, Cupedo, T., 2009. Interleukin-22-producing innate immune cells: New players in mucosal immunity and tissue repair ? Nat. Rev. Immunol. 9: 229 - 234.
139. Walzer, T., Jaeger, S., Chaix, J., and, Vivier, E., 2007. Natural killer cells: from CD3(-)NKp46() to post-genomics meta-analyses. Curr. Opin. Immunol. 19: 365 - 372.
140. Wang, H., and, Rudd, C.E., 2008. SKAP-55, SKAP-55-related and ADAP adaptors modulate integrin-mediated immune-cell adhesion. Trends Cell Biol. 18: 486 - 493.
141. Watzl, C., and, Long, E.O., 2003. Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J. Exp. Med. 197: 77 - 85.
142. Watzl, C., Stebbins, C.C., and, Long, E.O., 2000. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J. Immunol. 165: 3545 - 3548.
143. Welte, S., Kuttruff, S., Waldhauer, I., and, Steinle, A., 2006. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat. Immunol. 7: 1334 - 1342.
144. Woodside, D.G., Obergfell, A., Talapatra, A., Calderwood, D.A., Shattil, S.J., and, Ginsberg, M.H., 2002. The N-terminal SH2 domains of Syk and ZAP-70 mediate phosphotyrosine-independent binding to integrin beta cytoplasmic domains. J. Biol. Chem. 277: 39401 - 39408.
145. Wu, C.Y., and, Dedhar, S., 2001. Integrin-linked kinase (ILK) and its interactors: A new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J. Cell Biol. 155: 505 - 510.
146. Wu, J., Song, Y., Bakker, A.B., Bauer, S., Spies, T., Lanier, L.L., and, Phillips, J.H., 1999. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285: 730 - 732.
147. Yokoyama, W.M., and, Kim, S., 2006. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol. Rev. 214: 143 - 154.
148. Yu, M.C., Su, L.L., Zou, L., Liu, Y., Wu, N., Kong, L., Zhuang, Z.H., Sun, L., Liu, H.P., Hu, J.H., Li, D., Strominger, J.L., Zang, J.W., Pei, G., and, Ge, B.X., 2008. An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells. Nat. Immunol. 9: 898 - 907.
149. Zompi, S., Hamerman, J.A., Ogasawara, K., Schweighoffer, E., Tybulewicz, V.L., Di Santo, J.P., Lanier, L.L., and, Colucci, F., 2003. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat. Immunol. 4: 565 - 572.